Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Carcinoma, Non-Small-Cell Lung 2Tobacco Use Disorder 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Small Cell Lung Carcinoma 1Myeloproliferative Disorders 1Leukemia, Myeloid 1Leukemia 1Head and Neck Neoplasms 1Adenocarcinoma of Lung 1

Interventions

Tobacco Use Cessation Devices 5Surveys and Questionnaires 4Standard of Care 3Exercise 3Ethanol 3Varenicline 2Tomography, X-Ray Computed 2Tobacco Products 2Smoking Devices 2Radiotherapy 2Motivational Interviewing 2Celecoxib 2zileuton 1olaparib 1Yoga 1Vitamin B 12 1Videotape Recording 1Transcranial Direct Current Stimulation 1Tablets 1Restraint, Physical 1Radon 1Psychiatric Rehabilitation 1Preoperative Exercise 1Practice Guidelines as Topic 1Phlebotomy 1Patient Navigation 1Nutritional Support 1Nicotine Replacement Therapy 1Nicotine 1Mindfulness-Based Stress Reduction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Smoking × zileuton × Clear all
NCT01021215 2015-04-02

Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers

National Cancer Institute (NCI)

Phase 1/2 Completed
84 enrolled 10 charts

Smoking, Tobacco Use Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡